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Summary
Objectives There is no international consensus on the components of
anaphylaxis management plans and responsibility for their design and
delivery is contested. We set out to establish consensus among relevant
specialist and generalist clinicians on this issue to inform future
randomized controlled trials.
Design A two-round electronic Delphi study completed by a 25-person,
multidisciplinary expert panel. Participants scored the importance of a
range of statements on anaphylaxis management, identified from a
systematic review of the literature, on a five-point scale ranging from ‘very
important’ to ‘irrelevant’. Consensus was defined a priori as being
achieved if 80% or more of panel members rated a statement as
‘important’ or ‘very important’ after Round 2.
Setting Primary and secondary care and academic settings in the UK
and Ireland.
Participants Twenty-five medical, nursing and allied health
professionals.
Main outcome measures Consensus on the key components of
anaphylaxis management plans.
Results The response rate was 84% (n= 21) for Round 1 and 96%
(n= 24) for Round 2. The key components of emergency care on which
consensus was achieved included: awareness of trigger factors (100%);
recognition and emergency management of reactions of different severity
(100%); and clear information on adrenaline (epinephrine) use (100%).
Consensus on longer-term management issues included: clear written
guidelines on anaphylaxis management (96%); annual review of plans
(87%); and plans that were tailored to individual needs (82%).
Conclusions This national consensus-building exercise generated
widespread agreement that emergency plans need to be simple, clear and
generic, making them easy to implement in a crisis. In contrast, long-term
plans need to be negotiated between patient/carers and professionals,
and tailored to individual needs. The effectiveness of this expert-agreed
long-term plan now needs to be evaluated rigorously.
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Introduction
Anaphylaxis is a rapid onset and potentially
life-threatening condition with many possible
triggers.1,2 The true frequency of anaphylactic
reactions is unknown, but a recent epidemiologi-
cal review indicated that the incidence of anaphy-
laxis is approximately 50–2000 episodes per
100,000 person years, with a lifetime prevalence
of 0.05–2.0%.3 UK data suggest that the incidence
of anaphylaxis may be increasing.4,5 Annually, it
results in approximately 150 deaths in the US
and 20–30 reported deaths in the UK.6,7 Most
cases of anaphylaxis occur unpredictably in com-
munity settings, in the absence of a healthcare pro-
fessional.2,8 Management of anaphylaxis typically
focuses mostly on emergency treatment, specifi-
cally how to recognize reactions and the prompt
administration of intramuscular adrenaline (epi-
nephrine).1,2 Risk assessment and long-term, indi-
vidualized risk reduction and education along
with more effective self-management strategies
are, however, potentially crucial in preventing
severe and fatal anaphylactic episodes.2,6,7,9
Anaphylaxis management plans are increas-
ingly advocated internationally to improve out-
comes and reduce risk of recurrent reactions in
people with a history of anaphylaxis.2,10,11 Where
patients have access to allergy specialists, evi-
dence suggests that long-term management
plans may have successfully reduced the fre-
quency and severity of further reactions in chil-
dren and adults. One longitudinal case control
study, for example, reported an eight-fold
reduction in frequency of reactions and 60-fold
reduction in frequency of severe reactions in
peanut-allergic children following delivery of a
written anaphylaxis management plan.12 Allergy
clinic-based multidisciplinary team assessment,
training and management have also been associ-
ated with significant improvements in food avoid-
ance techniques, managing reactions, and the use
of adrenaline auto-injectors in children with ana-
phylaxis.13 These are encouraging data, but the
lack of control groups and potential for selection
and information biases means that these findings
need to be interpreted with caution.14,15
Other than the importance of adrenaline injec-
tion, there is no consensus on what should be
included in an anaphylaxis management plan.15
Moreover, the responsibility for design and
delivery of anaphylaxis management plans is con-
tested. It can be argued that the responsibility lies
appropriately with allergy specialists,16,17 but
given their paucity in many parts of the world,
such an approach may leave most patients with
severe allergies receiving minimal support in
managing their condition and experiencing sig-
nificant psychosocial consequences.6,18–20 Even
in healthcare systems where allergy specialists
are available, referrals for long-term management
advice are not routine,2 suggesting that clearer
guidelines on remits and responsibilities of
specialist and non-specialist staff are needed.
Current knowledge suggests that anaphylaxis
management plans may have substantial clinical
benefits for patients.12 A more robust methodo-
logical approach – ideally a randomized con-
trolled trial – would provide stronger evidence
of effectiveness and safety and is increasingly
seen as a needed piece of evidence prior to
routine implementation of anaphylaxis manage-
ment plans in national and international policies.
This does, however, also throw into sharp focus
the need to identify and develop agreement on
the key components of such plans. In the short
term, professional consensus on the components
of anaphylaxis management plans is useful, in
the absence of definitive evidence, for developing
clinical practice.21 In the longer term, randomized
controlled trials – which will, given the relative
infrequency of anaphylaxis, inevitably need to be
very large – will require professional agreement
on the utility and acceptability of the proposed
intervention. Regional consensus of expert
opinion on the key components of anaphylaxis
management plans is, therefore, an essential pre-
requisite for such future trials. With this in mind,
we aimed to identify and reach clinician consen-
sus on the most important and useful components
of anaphylaxis management plans for use in
future UK trials.
Methods
Initially, we conducted a systematic review of the
randomized controlled trial, and then other poten-
tially relevant experimental, epidemiological and
qualitative literature on anaphylaxis management.
We also contacted a panel of international anaphy-
laxis experts to identify anaphylaxis management
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plans in use worldwide and evaluate the evidence
for their effectiveness. The findings from these
reviews have recently been reported.14,15 These lit-
erature reviews enabled us to identify the core
issues concerning anaphylaxis management to
inform the consensus-seeking process.
In order to establish professional consensus on
the most relevant criteria of anaphylaxis manage-
ment plans, we used an adaptation of the Delphi
technique. This is a method of reaching consensus
on a particular research question and has been
widely used in healthcare research.22,23 It involves
circulating a set of statements, assumptions, sol-
utions or options to be anonymously scored by par-
ticipants, thereby minimizing the risk of actual or
perceived peer pressure influencing participants’
responses. Median scores and percentage agree-
ments on the statements are then circulated to
the participants who re-score them in the light
of other participants’ responses. Our adaptation
involved undertaking this consensus-building
work through e-mail rounds rather than face-to-
face meetings, thereby allowing us to engage with
our geographically dispersed expert panel in an
efficient and cost-effective way. Figure 1 shows the
e-Delphi process as used in this study.
The first stage of the e-Delphi process was to
identify the panel of experts to participate in the
study. To reflect an adequate breadth of expertise
and perspectives we purposively selected an
expert panel of 26 members with direct experience
of anaphylaxis management, drawn from those in
clinical and academic healthcare settings in the
UK and Ireland. An invitation to participate in
the study, sent jointly from the research team
and the Anaphylaxis Campaign, was e-mailed to
an expert panel of allergy specialists/practitioners
with a particular interest in allergy drawn from
internal medicine, nursing and allied health pro-
fessionals, family physicians and school nurses
(Table 1).
The e-Delphi questionnaire was designed by
identifying, through the systematic literature
review,15 key potential issues in emergency and
long-term anaphylaxis management for patients,
families and professionals. The issues were for-
malized into 34 statements, which were presented
in the questionnaire in two sections: components
of anaphylaxis management plans and general
issues identified from the literature as contentious.
Participants were asked to score the importance of
each statement on a five-point Likert scale ranging
from ‘very important’ to ‘irrelevant’. Free text
comments were encouraged in order to capture
the reasons for participants’ opinions. The ques-
tionnaire was piloted with five professionals.
Following Round 1, we calculated the median
score and the percentage agreement for each
item using SPSS (v14.0). These values were incor-
porated into the Round 2 questionnaire and panel
members were asked to re-score each item with
knowledge of what other panel members had
overall scored each item in Round 1. An additional
question (Q 35) was added to the Round 2 ques-
tionnaire, in response to strongly-expressed
views from a number of panel members in
Round 1 that emergency and long-term manage-
ment issues should be considered separately.
Figure 1
Flow chart for e-Delphi study
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All information was then collated and assessed
for consensus. Consensus was defined a priori as
having been achieved if 80% or more of the panel
members rated a statement as ‘very important/
strongly agree’ or ‘important/agree’ after Round 2.
Free text comments were collated and content
analysis undertaken to capture the range and
strength of opinions expressed.
Results
Twenty-five of the 26 experts initially approached
agreed to participate. We achieved a response rate
of 84% (n= 21) to Round 1 and 96% (n= 24) to
Round 2. There was over 80% agreement of impor-
tance on 20 of the 35 statements after Round 2, this
including the need separately to consider emer-
gency and long-term management considerations.
The items which it was agreed should form
part of an emergency anaphylaxis management
plan are shown in Table 2. Overall, our findings
revealed strong support for a short simple emer-
gency plan focused on recognition of severity of
the reaction (100% agreement), prompt and appro-
priate treatment with adrenaline (100%), and sum-
moning of emergency services (100%).
Consensus was achieved on certain principles
of long-term management (Table 3), these includ-
ing the need for clear guidelines in healthcare,
school and work settings (96%), the need for
regular review of plans (87%) and the need for
personalized plans tailored to the individual’s
Table 1
Demographic and professional characteristics of Delphi expert
panel
Panellist no. Gender Professional
background
Professional
role
1 F Medicine-allergy
specialist
Clinical
2 M Medicine-allergy
specialist
Clinical
3 M Medicine Academic/Clinical
4 M Paediatrician Academic/Clinical
5 M Immunologist Clinical
6 M Medicine-allergy
specialist
Clinical
7 F Nursing Nurse Advisor
8 M Immunologist Clinical
9 M GP Academic/Clinical
10 M GP Academic/Clinical
11 F Nursing Policy/Research
12 M GP Academic/Clinical
13 F Dietician Academic/Clinical
14 M Medicine Hospital consultant
15† M GP Clinical
16 F Paediatrician Clinical
17‡ F Pharmacy Academic
18 M Paediatrician Academic/Clinical
19 F Nursing Policy/Academic
20 F Nursing Academic/Clinical
21 M Medicine Academic/Clinical
22 M Paediatrician Clinical
23 F Nursing Academic/Clinical
24 M Medicine Academic/Clinical
25 F Nursing Academic/Clinical
26 F Nursing Academic/Clinical
Non-responders Round 1
†Non-responders Round 2
‡Not available: excluded
Table 2
Consensus on the components of emergency
anaphylaxis management plans in rank order
Components %
Contact details – names and numbers – for
emergencies, including familymembers to
be contacted in an emergency
100
Details of the individual’s allergies/known
trigger factors
100
Generic and proprietary names of drugs and
possible cross-sensitivities to drugs, if
relevant
100
How to recognize the signs and symptoms of
mild, moderate and severe allergic
reactions and how to act in each case
100
Medication prescribed and when it should
be used
100
Management of emergencies: actions to be
taken and medications to be used
100
Clear statement of the need to administer
adrenaline without hesitation
100
When to call emergency services 100
Where medication is stored at home, in
school, or workplace
96
Review dates for prescribed medication if
appropriate, e.g. when child reaches 30 kg
in weight, importance of checking expiry
dates
87
Number of injectable adrenaline devices
(e.g. Epipens) required
83
Who is trained to administer medication in
home, school, workplace
80
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particular circumstances (82%). Other aspects of
long-term management were contentious and
there were some differences which appeared to
reflect the professional role of the respondent
and whether allergy specialist services were avail-
able locally. Aspects of long-term anaphylaxis
management on which consensus was not
attained (Table 4) included whether non-
specialists in allergy can diagnose anaphylaxis
(70%), and design and deliver anaphylaxis man-
agement plans (78%). There was little support
for written advice on the social management of
risk (46%) and documentation of patients’ con-
cerns about the impact of anaphylaxis on their
lives (12%).
Free text comments by panel members
explained the scores given, raised uncertainties
and highlighted a number of contentious issues
in anaphylaxis management where views were
polarized.
Emergency anaphylaxis management
plans
Panel members indicated that clarity, simplicity
and brevity are the cornerstones of an emergency
anaphylaxis management plan. Clear advice
about recognizing the symptoms of mild, moder-
ate and severe reactions and how to respond was
viewed as crucial.
Table 3
Consensus on the principles of long-term ana-
phylaxis management in rank order
Principles %
Clear, written guidelines on anaphylaxis
management, including referral pathways,
should be in place in all healthcare, work
and school settings
96
Plans should be reviewed if a severe allergic
reaction occurs
96
Oral antihistamines, inhalers and/or
injectable adrenaline (e.g. Epipen), if
prescribed, should be accompanied by
information on their use
91
Anaphylaxis management plans should be
reviewed annually including reassessment
of patient/parent knowledge of anaphylaxis
management and emergency treatment
87
Quality Outcome Framework (QOF) targets
for anaphylaxis reviews in primary care
would improve standards of care
86
Plans should be reviewed when a child starts
nursery or a new school
83
Anaphylaxis management plans should be
personalized to the patient’s circumstances
and tailored to age
82
Anaphylaxis management plans should focus
on emergency care. Long-term
management plans should be addressed in
a separate document
80
Table 4
Statements on which consensus was not
attained in rank order
Statements %
For each patient, there should be a named
clinician responsible for planning,
coordinating and managing care for people
with a history of anaphylaxis
78
GPs, school nurses and/or practice nurses, if
trained, can safely design and deliver
anaphylaxis management plans
78
The diagnosis of anaphylaxis should be
confirmed by an allergy specialist
70
Written advice on dietary management, if
relevant
67
An indemnity statement for school and
workplace staff involved in administering
adrenaline
65
Injectable adrenaline (e.g. Epipen) should
only be prescribed when there is increased
risk, such as known airway involvement in
previous reaction, history of asthma or
reaction to even a trace of nut
61
Signatures of patient/parent, clinical staff,
head teacher, workplace staff as relevant
58
Contact details for information, advice and
support, including the Anaphylaxis
Campaign
54
Written advice on minimizing exposure to
bees and wasps, if relevant
50
Statement that anaphylaxis can be fatal 50
Written advice on managing specific social
situations, e.g. eating out, parties, school
trips, travel abroad, if relevant
46
An allergy specialist should design and
deliver anaphylaxis management plans
35
GPs should not prescribe injectable
adrenaline without referral to a specialist
26
Written advice on interpreting food labels, if
relevant
25
Record of discussion about particular
concerns the patient may have about impact
on lifestyle
12
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‘The management plan, I believe, should be very
simple and easy to read in a crisis.’ (Participant 7)
‘The anaphylaxis management plan should focus on
crisis avoidance and crisis response.’ (Participant 24)
‘Differentiation of grades of reaction of prime impor-
tance in determining appropriate self-treatment. V
[ery] important.’ (Participant 8)
The statements onmedications attained a high level
of consensus, but revealed some variations in prac-
tice, particularly in the number of adrenaline auto-
injectors prescribed, with participants reporting a
range of preferences from one to four. Factors
which contributed tomoreadrenaline auto-injectors
being prescribed included parental anxiety, geo-
graphical distance from emergency services and
individual patient circumstances. The importance
of all relevant parties taking responsibility for pre-
scribing and administering adrenalinewas stressed:
‘Failure to take responsibility could lead to
unnecessary death.’ (Participant 9)
Long-term anaphylaxis management
plans
Long-term advice and management concerning
factors such as minimizing exposure to risk and
management of social situations was seen as
important, but part of a separate package of care:
‘It is good advice, but will dilute the action plan.’
(Participant 24)
Clear distinctions were made between acute and
long-term management:
‘Acute management should be simple, didactic and
generic and NOT tailor-made. Preventive plans
absolutely important to individualize with a
generic component and specific tailor-made
aspects.’ (Participant 3)
There were diverse views about the level of detail
required in long-term plans. Some expressed
doubt about the value of written advice on avoid-
ance, describing it as ‘commonsense surely’ (Partici-
pant 9), or not useful. Written advice on dietary
management, interpreting food labels and manage-
ment of social situations was not well-supported.
A wide range of views was also expressed on the
regularity of which an anaphylaxis management
plan should be reviewed, from two- to three-
monthly to three-yearly, but overall the importance
of regular reviews was stressed:
‘It is an under-appreciated reason why allergy ser-
vices need support as the ongoing needs of families
after diagnosis are almost as great as the need for a
diagnosis in the first place. This review is in the
remit of an experienced practice nurse or specialist
hospital nurse.’ (Participant 24)
Consensus was attained on the separation of emer-
gency and long-term anaphylaxis management
plans (80%).
‘Absolutely.Anaphylaxis plans should be very short
and easy to read. Patients and carers cannot read
detailed documents in an emergency.’ (Participant 7)
‘There could be a separate area within the document to
detail specifics for that individual… Preventative
issues might be recorded in an area of this document.
Long-term management and emergency care should
in someways cross over and be thought about together
as one component in the care.’ (Participant 19)
‘No need for second document – over-bureaucratic.
Plan needs to fit into Epipen box, purse or wallet if
what to do in emergency is to make any sense at all.’
(Participant 25)
Specialist and generalist roles
in anaphylaxis management
Many respondents drew a distinction between the
‘ideal world’, where ‘everyone with anaphylaxis
should see a specialist’ (Participant 1), and reality,
where there are ‘too few allergists to go round’ (Par-
ticipant 3), where specialist clinics may have long
waiting lists and there are major geographical gaps
in provision of specialist services. Some participants
indicated that allergy specialists should have the
major responsibility for design and delivery of ana-
phylaxis management plans, due to their ability to
make an accurate diagnosis and give expert
advice. The lack of access for many patients to
such specialists led most participants to suggest
that primary care will play a key role:
‘In the UK with poor access to allergists the primary
care team must be able to form an initial
J R Soc Med Sh Rep 2010;1:42. DOI 10.1258/shorts.2010.010060
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management plan including instruction in the use
of EpiPens and when to use prior to being seen by
an allergist.’ (Participant 9)
Concerns were expressed that GPs and school
nurses may lack sufficient understanding of ana-
phylaxis and consequently provide inadequate
information and training for patients/parents in
anaphylaxis management and the use of injectable
self-administered adrenaline. The key to effective
management was, therefore, seen as: clear delinea-
tion of roles and responsibilities; adequate train-
ing for primary care and education staff in
anaphylaxis management; defined competencies;
clearer guidelines; an integrated, cross-sector,
multidisciplinary approach to anaphylaxis man-
agement; sufficient resources to support specialist
services and increase capacity in primary care.
These were, however, considered by participants
to be largely lacking in current practice.
The components of emergency and
long-term anaphylaxis management plans
Based on the UK professional consensus attained
in this study, we can recommend the components
of emergency anaphylaxis management plans
(Table 5). Consensus on the underpinning prin-
ciples of long-term anaphylaxis management on
which plans should be based included:
• Anaphylaxis management plans should be per-
sonalized to the patient’s circumstances and tai-
lored to age;
• Clear,writtenguidelinesonanaphylaxismanage-
ment, including referral pathways, should be in
place in all healthcare, work and school settings;
• Plans should be reviewed regularly and also if a
severe allergic reaction occurs and at significant
times such as when a child starts nursery or a
new school;
• Oral antihistamines, inhalers and/or injectable
adrenaline, if prescribed, should be
accompanied by clear information on their use.
Discussion
Our study has highlighted the view that emer-
gency and long-term anaphylaxis management
plans should be stand-alone documents. The
greatest consensus was around the components
of an emergency anaphylaxis management plan,
which participants indicated should be a simple,
clear and brief, generic and easy to implement in
a crisis situation. Responsibility for long-termman-
agement plans, particularly where specialist ser-
vices are unavailable, was more controversial.
Long-term anaphylaxis management plans need
to be negotiated between patient/family and pro-
fessionals and tailored to individual needs.
This study supports the view that long-term
management of anaphylaxis is in the main inade-
quately addressed.2,24,25 Ideally, all patients with
anaphylaxis should have a comprehensive assess-
ment which covers issues relating to emergency
management and discussion of ways of minimiz-
ing further reactions, with appropriate written
information, access to expert advice and follow-up
review and retraining if necessary.2,7,10,12,26 Our
Table 5
Recommended components of a plan for mana-
ging anaphylactic emergencies
Recommended components
Contact details – names and numbers – for
emergencies, including family members to be
contacted in an emergency
Details of the individual’s allergies/known trigger
factors
Generic and proprietary names of drugs and
possible cross-sensitivities to drugs, if relevant
How to recognize the signs and symptoms of
mild, moderate and severe allergic reactions
and how to act in each case
Medication prescribed and when it should be
used
Management of emergencies: actions to be taken
and medications to be used
Clear statement of the need to administer
adrenaline without hesitation
When to call emergency services
Where medication is stored at home, in school, or
workplace
Review dates for prescribed medication if
appropriate, e.g. when child reaches 30 kg in
weight, importance of checking expiry dates
Number of injectable adrenaline devices (e.g.
Epipens) required
Who is trained to administer medication in home,
school, workplace
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study suggests, however, that policy and practice
in anaphylaxis management are fragmented,
with much local variation in care provision.
Allergy patients are often managed by non-
specialists, but clearly defined referral pathways
to specialists for patients with severe disease are
required. Specialists may in particular need to
see children at key transition points, such as start-
ing a new school (nursery, primary or secondary)
or leaving home. More effective long-term ana-
phylaxis management requires education for non-
specialists to enhance their skills and confidence.
The lack of specialist services in many countries
means that non-specialist healthcare and school
staff have little access to such training and
support from specialists, therefore establishing
competencies in anaphylaxis management at all
clinical levels is essential for effective long-term
management and review for children and
adults.27 The low numbers of patients with ana-
phylaxis means that experience of anaphylaxis
management is hard to come by for generalist
staff and integrated cross-sector working in
allergy is uncommon. There appears to be a
danger that no-one, in the absence of an allergy
specialist clinic or a dedicated school nurse or a
community-based practitioner with a special
interest in allergy, takes responsibility for long-
term management of anaphylaxis. This mirrors
parents’ experiences in previous studies.18,19,28
Professional consensus on the key aspects of
anaphylaxis management does not necessarily
coincide with the views of patients and families.
The panel of experts did not identify psychosocial
support, such as specific advice on managing
social situations, as important, although parents
have identified this as a major concern in risk
management with adolescents.18,29 Support and
advice to enable those affected by anaphylaxis to
live a normal social and family life through effec-
tive risk management could potentially improve
quality of life and reduce morbidity and
mortality.10,30
Strengths and limitations
It is vital to ensure that any proposed intervention
is acceptable to the academics and professionals in
the areas in which evaluative studies are likely to
be conducted and, furthermore, that any future
change in clinical practice is relevant and accepta-
ble to clinicians. The e-Delphi process was highly
effective in engaging a diverse group of academics
and professionals as evidenced by the very high
response rates. This process enabled a structured,
systematic approach to be taken to developing
consensus from experts in the field and allowing
all voices to be heard equally, thereby resulting
in a clinically-relevant strategy for anaphylaxis
management, while also recognizing divergent
views. Despite assurances of confidentiality,
however, some contributors may still have had
doubts about whether or not others might have
been able to identify them and this may have
influenced their responses. Consensus between
clinicians and patients/families also needs to be
established before anaphylaxis management
plans can be successfully implemented.
Implications for practice, policy
and research
Consensus on the core components of emergency
anaphylaxis management plans exists and the evi-
dence base for their implementation is probably
adequate to inform policy decisions, given the
challenges inherent in conducting research in the
context of a relatively uncommon, acute and short-
lived emergency. The emergency component of
anaphylaxis management plans should, therefore,
be implemented nationally. There is less agree-
ment, however, on aspects of long-term manage-
ment and the evidence-base for the effectiveness
of strategies to reduce risk and severity of recur-
rence requires further development. Tailored
plans, individualized to the patient’s age, under-
lying triggers and circumstances, are required,
but currently not routinely used in practice and
the agreed components of anaphylaxis manage-
ment plans identified in this study should now
be evaluated. Protocols for use in schools and
workplaces and referral pathways should also be
developed and will require robust evaluation of
impact, including cost–benefit analysis, when
they are implemented.
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